Fig. 5From: Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptidesIn vitro release of afatinib from LPN or LPN-HR at pH 7.4 or 6.5. The afatinib release profile from different formulations was performed in dialysis bag at pH 7.4 or 6.5. Data are shown as mean ± SD, n = 3Back to article page